Virus variation, escape from cytotoxic T lymphocytes and human retroviral persistence

被引：7

作者：

Gould, KG ^{[1
]}

Bangham, CRM ^{[1
]}

机构：

[1] Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Immunol, London W2 1PG, England

来源：

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY | 1998年 / 9卷 / 03期

基金：

英国惠康基金;

关键词：

virus; sequence variation; mutation selection; immune escape;

D O I：

10.1006/scdb.1998.0241

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Viruses use a variety of mechanisms to escape recognition by cytotoxic T lymphocytes (CTL). The available evidence suggests that the main mechanisms of CTL escape caused by viral sequence variation are loss of epitope binding to MHC molecules or altered recognition by T cell receptors. These types of mutations occur in both human immunodeficiency virus type 1 (HIV-1) and human T cell leukaemia virus type 1 (HTLV-1) infections. In HIV-1, CTL escape is one factor that may cause progression of disease. In HTLV-I, however, CTL escape mutants never predominate in the viral population.

引用

页码：321 / 328

页数：8

共 44 条

[11] FLANKING SEQUENCES INFLUENCE THE PRESENTATION OF AN ENDOGENOUSLY SYNTHESIZED PEPTIDE TO CYTOTOXIC LYMPHOCYTES-T [J].

EISENLOHR, LC ;

YEWDELL, JW ;

BENNINK, JR .

JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (02) :481-487

[12] HIGH HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-1 (HTLV-1) SPECIFIC PRECURSOR CYTOTOXIC T-LYMPHOCYTE FREQUENCIES IN PATIENTS WITH HTLV-1 ASSOCIATED NEUROLOGICAL DISEASE [J].

ELOVAARA, I ;

KOENIG, S ;

BREWAH, AY ;

WOODS, RM ;

LEHKY, T ;

JACOBSON, S .

JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (06) :1567-1573

[13] ALLELE-SPECIFIC MOTIFS REVEALED BY SEQUENCING OF SELF-PEPTIDES ELUTED FROM MHC MOLECULES [J].

FALK, K ;

ROTZSCHKE, O ;

STEVANOVIC, S ;

JUNG, G ;

RAMMENSEE, HG .

NATURE, 1991, 351 (6324) :290-296

[14] Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS [J].

Goulder, PJR ;

Phillips, RE ;

Colbert, RA ;

McAdam, S ;

Ogg, G ;

Nowak, MA ;

Giangrande, P ;

Luzzi, G ;

Morgan, B ;

Edwards, A ;

McMichael, AJ ;

RowlandJones, S .

NATURE MEDICINE, 1997, 3 (02) :212-217

[15] RESTRICTION OF SELF-ANTIGEN PRESENTATION TO CYTOLYTIC T-LYMPHOCYTES BY MOUSE PEPTIDE PUMPS [J].

GOURNIER, H ;

PASCOLO, S ;

SIEGRIST, CA ;

JEHAN, J ;

PERARNAU, B ;

GARCIA, Z ;

ROSE, T ;

NEEFJES, J ;

LEMONNIER, FA .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (07) :2019-2026

[16]

Iwasaki A, 1997, J IMMUNOL, V158, P4591

[17] CIRCULATING CD8+ CYTOTOXIC LYMPHOCYTES-T SPECIFIC FOR HTLV-I PX IN PATIENTS WITH HTLV-I ASSOCIATED NEUROLOGICAL DISEASE [J].

JACOBSON, S ;

SHIDA, H ;

MCFARLIN, DE ;

FAUCI, AS ;

KOENIG, S .

NATURE, 1990, 348 (6298) :245-248

[18] CLONE-SPECIFIC T-CELL RECEPTOR ANTAGONISTS OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I RESTRICTED CYTOTOXIC T-CELLS [J].

JAMESON, SC ;

CARBONE, FR ;

BEVAN, MJ .

JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (06) :1541-1550

[19] Impaired induction of cytotoxic T lymphocytes by antagonism of a weak agonist borne by a variant hepatitis C virus epitope [J].

Kaneko, T ;

Moriyama, T ;

Udaka, K ;

Hiroishi, K ;

Kita, H ;

Okamoto, H ;

Yagita, H ;

Okumura, K ;

Imawari, M .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (07) :1782-1787

[20] PREDOMINANT RECOGNITION OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I (HTLV-I) PX GENE-PRODUCTS BY HUMAN CD8+ CYTOTOXIC T-CELLS DIRECTED AGAINST HTLV-I-INFECTED CELLS [J].

KANNAGI, M ;

HARADA, S ;

MARUYAMA, I ;

INOKO, H ;

IGARASHI, H ;

KUWASHIMA, G ;

SATO, S ;

MORITA, M ;

KIDOKORO, M ;

SUGIMOTO, M ;

FUNAHASHI, S ;

OSAME, M ;

SHIDA, H .

INTERNATIONAL IMMUNOLOGY, 1991, 3 (08) :761-767

← 1 2 3 4 5 →